Feed Preview

Fast Growing

Statin Medications & Heart Disease

Statin Medications & Heart Disease diagram by Jatlas2, Wikimedia
Jatlas2, Wikimedia

Statins or HMG-CoA reductase inhibitors, are used clinically to lower cholesterol levels and have been associated with decreased risk of heart disease. Discover the latest research on Statin Medications & Heart Disease here.

Top 20 most recent papers
European Journal of Preventive Cardiology

LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial

European Journal of Preventive CardiologyFebruary 6, 2020
Peter SeverMichelle L O'Donoghue
Stroke; a Journal of Cerebral Circulation

Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke

Stroke; a Journal of Cerebral CirculationFebruary 21, 2020
Pierre AmarencoTreat Stroke to Target (TST) Committees and Investigator Centers
Cardiovascular Research

Treatment of coronary microvascular dysfunction

Cardiovascular ResearchFebruary 23, 2020
C Noel Bairey MerzColin Berry
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions

Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & InterventionsMarch 13, 2020
Jaya ChandrasekharSamin Sharma
Biochemical Pharmacology

Repurposing of drugs approved for cardiovascular diseases: opportunity or mirage?

Biochemical PharmacologyMarch 8, 2020
Paolo GelosaLuigi Sironi
Nederlands tijdschrift voor geneeskunde

PCSK9 inhibitors; who benefits from these new cholesterol-lowering drugs?

Nederlands tijdschrift voor geneeskundeMarch 19, 2020
Anouk J W GulpenFloris H M Vanmolkot
Hypertension Research : Official Journal of the Japanese Society of Hypertension

Low blood pressure and cardiovascular events in diabetic patients with coronary artery disease after revascularization: the CREDO-Kyoto registry cohort-1

Hypertension Research : Official Journal of the Japanese Society of HypertensionFebruary 5, 2020
Hisashi KaiCREDO-Kyoto Investigators
FP Essentials

Acute Coronary Syndrome: Management

FP EssentialsMarch 10, 2020
Michael Braun, David Kassop

Secondary prevention of cardiovascular disease in China

HeartJanuary 26, 2020
Jiapeng LuXin Zheng
Cardiovascular Drugs and Therapy

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity

Cardiovascular Drugs and TherapyFebruary 9, 2020
Kerstin N Timm, Damian J Tyler

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2020 Meta ULC. All rights reserved